Radiolabeled Monoclonal Antibody Followed by Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Metastatic Breast Cancer

NCT00020410 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: filgrastim
PROCEDURE: peripheral blood stem cell transplantation
RADIATION: yttrium Y 90 monoclonal antibody B3

Sponsor

National Cancer Institute (NCI)